Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Absent, absolute, accrual, add, adhere, adjacent, agency, albeit, Alimta, AmerisourceBergen, ance, Andover, angiogenic, Basal, begun, billon, Brazil, buyout, carboplatin, cas, CFO, Chain, character, chemotherapeutic, Chi, cial, Citizen, commer, competi, complicated, Concurrently, condensed, contaminati, contemplated, contra, contrary, COSO, crucial, CTDB, cult, CVP, cycle, cyclophoshamide, debate, delete, demonstrated, deoxyribonuclease, detect, detection, deteriorate, developmental, dialogue, Diffi, Difficulti, disclaim, Disrupt, disruptive, docetaxel, DOH, dysfunctional, ear, earni, Electric, employed, Enterprise, EPS, equence, ERBITUX, Erich, ERM, ess, ethical, ethically, exacerbation, fact, false, fewer, fill, filling, foot, formidable, fraudulent, fundamental, gemcitabine, goal, greatly, hard, hire, Horizon, Hunziker, illegal, ImClone, induce, infrastructure, ingle, inInternal, integrate, Integration, intolerant, introduced, Iressa, irinotecan, ISEL, Israel, joint, Journal, Justice, knowingly, leadership, ledger, legacy, lessen, liab, library, lie, lytic, malfunction, man, Master, mediator, merged, modestly, mutual, NCA, nerve, Neuroscience, NGF, nto, olution, onthe, orceability, outlined, Outpatient, Oversight, ovide, oxygen, oyalty, page, pain, Patrick, pollutant, population, pr, preapproval, predicated, prednisone, prepaid, prioritization, procurement, prog, protocol, prove, Qualitative, quickly, rapid, reaction, rebate, rebuild, reconsideration, redevelopment, referenced, referral, refined, remitting, remuneration, renegotiated, repair, resource, ressa, retire, rhDNase, RI, Rinat, role, ron, run, shape, shift, shifted, significantl, silo, situation, Slough, solicit, sought, speed, SSF, Stakeholder, subpoena, substance, substantive, sui, systematic, taxane, Taxotere, TCH, tender, theimplementation, thereon, thousand, thrombo, tion, Topical, toxic, transparency, Treadway, ufacturing, unabsorbed, unamortized, unauthorized, underinsured, undertaken, unenf, unintended, unnecessary, unqualified, vacant, VEGF, Venezuela, vincristine, William, willingly, workshop, Yang, Zealand
Removed:
AERx, affiliated, arbitration, aware, Bexxar, bind, black, cardiovascular, complying, consultation, Corixa, discover, essential, franz, genetic, hearing, humer, ibritumomab, incorporate, individually, inserted, iodine, managing, Millennium, overexpressing, Pharmacia, Porrino, prejudice, prelicensing, produced, radiolabeled, respiratory, returned, ruling, secretion, solid, stable, tiuxetan, tositumomab, vertical, Xanelim, Zevalin
Filing tables
Filing exhibits
- 10-K Annual report
- 10.25 Amended and Restated Backup Facility Agreement and Amendment to Other Operative Agreements, Dated As of November 4, 2004, Among Dna Finance Corp, JP Morgan Bank and Various Financial Institutions Named Therein.
- 10.27 Master Lease Agreement, Dated As of November 1, 2004, Between Genentech and Slough SSF, LLC.
- 23.1 Consent Independent Registered Public Accounting Firm.
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended.
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended.
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- PDF "Unofficial" PDF Copy of the Form 10-K (December 31, 2004)
Genentech similar filings
External links